To investigate hepatic molecular changes that occur with lipodystrophy and FGF21 treatment, bulk RNA-Seq analyses were performed, and data were analyzed using gene set enrichment analysis (GSEA) to identify transcriptomic patterns (Figure 10A). The gene discussed is FGF21; the disease is lipodystrophy.